Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s displayed interface/version label has been updated from “v3.5.0” to “v3.5.3,” indicating a site revision rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-25T18:25:02.000Z thumbnail image
  3. Check
    26 days ago
    No Change Detected
  4. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed in the study history. This is a minor version-tracking update and does not modify study data or page content.
    Difference
    0.0%
    Check dated 2026-03-20T19:48:26.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history log.
    Difference
    0.0%
    Check dated 2026-03-06T18:16:30.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Record history now shows a new revision (v3.4.2) and removes the previous revision (v3.4.1), updating the revision sequence for this study.
    Difference
    0.0%
    Check dated 2026-02-13T13:28:34.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page history shows the addition of revision v3.4.1 and the removal of revision v3.4.0. This is a minor metadata update to the site's revision records and does not affect trial data or core content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:20:51.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    The page history shows a new revision entry: Revision: v3.3.4 added and Revision: v3.3.3 removed, reflecting a minor behind-the-scenes update with no changes to study data or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:57:32.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.